BACKGROUND Morphological differences in the patterns of coronary artery and peripheral artery atherosclerosis have not been well described.
METHODS CLARITY was a prospective, multi-center trial in which 50 peripheral arterial disease (PAD) pts with a lower extremity wound fed by a diseased tibial or peroneal artery with diameter stenosis >50% were enrolled to evaluate orbital atherectomy compared to balloon angioplasty alone using intravascular ultrasound (IVUS). ADAPT-DES was a prospective, multicenter, "all-comers" registry of 8582 coronary artery disease (CAD) pts undergoing successful percutaneous coronary intervention (PCI); a pre-specified substudy included 780 pts with baseline IVUS data. We compared pre-intervention IVUS findings in 42 PAD lesions from CLARITY vs 79 CAD lesions from ADAPT that were matched 1:2 for age, gender, diabetes, hypertension, hyperlipidemia, and renal insufficiency. Vessel and lumen were measured every 1 mm, and total volume and mean volume (¼volume/length) were calculated. Furthermore, within each lesion 5 equidistantly spaced cross-sections from the proximal to the distal edge were identified, and calcium arc and plaque eccentricity (min/max plaque thickness) were analyzed.
RESULTS Compared to CAD lesions, PAD lesions had 1) smaller mean vessel, plaque and lumen volumes; and 2) twice the lesion length (Table) . Maximum superficial calcium arc and plaque eccentricity measures at the MLA were greater (ie. more concentric plaque) in PAD lesions than in CAD lesions. Calcium arc and plaque eccentricity were positively correlated to the plaque burden (PB) in both PAD and CAD lesions (Figure) . Calcium arc and concentricity were greater in PAD compared to CAD independent of the degree of plaque burden (PB) (Table) . BACKGROUND Serial evolution in untreated coronary lesion morphology associated with and without cardiac events has not previously been prospectively described.
PAD
METHODS In PROSPECT, 3-vessel grayscale and virtual histology intravascular ultrasound (VH)-IVUS was performed in 697 acute coronary syndrome pts following successful PCI. By protocol, repeat 3vessel VH-IVUS was to be performed at the time of major adverse cardiac events (MACE). BACKGROUND Coronary calcification is a common finding in noninvasive and invasive imaging studies. Coronary computed tomography (CT) coronary artery calcium (CAC) testing is the most widely used and validated score for studying coronary calcification. It is considered to be a strong independent predictor of future adverse cardiovascular events and also gives additional information than the traditional cardiovascular risk factors. We investigated the natural history of the coronary calcification as assessed by OCT in a population with serial imaging over a period of 5 years.
RESULTS
METHODS We screened all patients from ABSORB cohort B trial and we selected only the patients with available OCT data within 6 months (baseline) after scaffold implantation and at follow-up (5 years). In the ABSORB B trial (n¼101) patients with a diagnosis of stable or unstable angina or silent ischemia were enrolled and treated with implantation of ABSORB (3.0 x 18 mm). OCT datasets (baseline and 5 year followup) were screened for the presence of calcium spots fully visible in their entire extent without the presence of any artifact that may prevent proper contouring of the calcium area.
RESULTS A total of 17 patients had 31 matched lesions with calcified spots at baseline and 5 year follow-up (21 were located outside of the scaffolded segments and 10 in the scaffolded segments). At baseline, the median calcium area (IQR) was 0.44 (0.28-0.72) vs. 0.75 (0.61-0.90) mm2 at 5 years; the mean difference was 0.38AE0.50 mm2, p<0.001 (representing an 110AE96.3% increase). The rate of progression seems to be slower in those calcium spots within the scaffolded segments compared to those located outside the scaffolded segments. The mean minimum, maximum and mean distances from the lumen remain unchanged over time. On average, the circumferential arc of the calcium reduced slightly (although statistically significant) from 49.18 to 45.98 degrees while the length of the calcium increased not significantly (table 1) .
CONCLUSIONS Near-microscopic resolution intravascular imaging modality, such as OCT, allows a very detailed and highly reproducible analysis of the calcium spots. This provides a unique opportunity to study the natural history of coronary calcium. In a period of 5 years, the measured calcium spots doubled their size. METHODS An independent corelab (Cardialysis, Rotterdam, The Netherlands) analyzed IVUS segments flanked by the presence of side branches beyond 5mm distally and 5mm proximally to the to be treated regions. Patient demographics, anthropometric measures, cardiovascular risk factors and baseline SAQ were correlated with IVUS findings. A multivariate analysis was run to identify variables related to plaque burden and the largest necrotic core area in these obstructive lesions.
RESULTS 464 patients had pre-procedural IVUS grey-scale and 438 patients had IVUS radiofrequency assessment before device implantation. The mean age was 61.5AE10.0 years old, 23.3% were female and 25.0% were diabetics. Clinical characteristics were able to differentiate plaque features by IVUS and VH IVUS. Patients with abdominal obesity (P<0.01) and increase in body mass had more negative remodeling (P¼0.01), a finding that was related to worse angina frequency scores by SAQ (P<0.01). Reduction in HDL-C (P¼0.01), lesion in RCA (P<0.01), lesion in proximal LAD (P<0.01) and worse angina stability by SAQ (P¼0.03) were independently correlated with plaque burden. Smaller lumen area (P<0.01), larger vessel area (P<0.01) and more physical limitation by SAQ (P¼0.03) were independently correlated with the maximum necrotic core area. 
